306 related articles for article (PubMed ID: 1922235)
1. A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group.
Handsfield HH; McCormack WM; Hook EW; Douglas JM; Covino JM; Verdon MS; Reichart CA; Ehret JM
N Engl J Med; 1991 Nov; 325(19):1337-41. PubMed ID: 1922235
[TBL] [Abstract][Full Text] [Related]
2. Oral cefixime versus intramuscular ceftriaxone in patients with uncomplicated gonococcal infections.
Portilla I; Lutz B; Montalvo M; Mogabgab WJ
Sex Transm Dis; 1992; 19(2):94-8. PubMed ID: 1534422
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of ceftriaxone and spectinomycin in the treatment of uncomplicated gonorrhea in women.
Collier AC; Judson FN; Murphy VL; Leach LA; Root CJ; Handsfield HH
Am J Med; 1984 Oct; 77(4C):68-72. PubMed ID: 6093523
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhea in pregnancy.
Ramus RM; Sheffield JS; Mayfield JA; Wendel GD
Am J Obstet Gynecol; 2001 Sep; 185(3):629-32. PubMed ID: 11568790
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of cefotaxime and ceftriaxone in patients with uncomplicated gonorrhea.
Jones RB; Mogabgab WJ; McCormack WM; Wendel GD
Clin Ther; 1991; 13(5):550-6. PubMed ID: 1799912
[TBL] [Abstract][Full Text] [Related]
6. Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection.
Plourde PJ; Tyndall M; Agoki E; Ombette J; Slaney LA; D'Costa LJ; Ndinya-Achola JO; Plummer FA
J Infect Dis; 1992 Oct; 166(4):919-22. PubMed ID: 1527431
[TBL] [Abstract][Full Text] [Related]
7. Multicenter trial of fleroxacin versus ceftriaxone in the treatment of uncomplicated gonorrhea.
Smith BL; Mogabgab WJ; Dalu ZA; Jones RB; Douglas JM; Handsfield HH; Hook EW; Viner BL; Shands JW; McCormack WM
Am J Med; 1993 Mar; 94(3A):81S-84S. PubMed ID: 8452187
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of 250 mg trospectomycin sulfate i.m. vs. 250 mg ceftriaxone i.m. for treatment of uncomplicated gonorrhea.
Rompalo AM; Colletta L; Caine VA; Linnemeier P; Neumann T; Hook EW; Jones RB
Sex Transm Dis; 1994; 21(4):213-6. PubMed ID: 7974072
[TBL] [Abstract][Full Text] [Related]
9. Treatment of gonococcal infections with a single 250 mg intramuscular injection of trospectomycin sulphate vs ceftriaxone sodium.
Mroczkowski TF; Millikan LE; Martin DH; Leonik KJ
Drugs Exp Clin Res; 1993; 19(1):41-6. PubMed ID: 8223139
[TBL] [Abstract][Full Text] [Related]
10. Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):590-4. PubMed ID: 22874837
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of treatment with single-dose ampicillin/sulbactam with probenecid or ceftriaxone in patients with uncomplicated gonorrhea.
Baddour LM; Busby L; Shapiro E; Cox KB; Glassco S; Johnson JK
Sex Transm Dis; 1992; 19(6):341-5. PubMed ID: 1492262
[TBL] [Abstract][Full Text] [Related]
12. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
Tapsall JW
Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600
[TBL] [Abstract][Full Text] [Related]
13. Ceftriaxone for treatment of uncomplicated gonorrhea: routine use of a single 125-mg dose in a sexually transmitted disease clinic.
Handsfield HH; Hook EW
Sex Transm Dis; 1987; 14(4):227-30. PubMed ID: 3438787
[TBL] [Abstract][Full Text] [Related]
14. Treatment of uncomplicated gonorrhea with single doses of 200 mg cefixime.
Verdon MS; Douglas JM; Wiggins SD; Handsfield HH
Sex Transm Dis; 1993; 20(5):290-3. PubMed ID: 8235928
[TBL] [Abstract][Full Text] [Related]
15. Cefixime in the treatment of uncomplicated gonorrhea.
Dunnett DM; Moyer MA
Sex Transm Dis; 1992; 19(2):92-3. PubMed ID: 1595018
[TBL] [Abstract][Full Text] [Related]
16. Results of treatment of uncomplicated urogenital gonorrhoea with enoxacin compared with ceftriaxone.
Calderón E; Conde-Glez C; Echaniz G; Arredondo JL; Olvera J; Hirata C; Villafaña M
Int J Clin Pharmacol Res; 1988; 8(4):247-51. PubMed ID: 3141301
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness decision analysis of intramuscular ceftriaxone versus oral cefixime in adolescents with gonococcal cervicitis.
Friedland LR; Kulick RM; Biro FM; Patterson A
Ann Emerg Med; 1996 Mar; 27(3):299-304. PubMed ID: 8599487
[TBL] [Abstract][Full Text] [Related]
18. Multicenter, comparative study of cefotaxime and ceftriaxone for treatment of uncomplicated gonorrhea.
McCormack WM; Mogabgab WJ; Jones RB; Hook EW; Wendel GD; Handsfield HH
Sex Transm Dis; 1993; 20(5):269-73. PubMed ID: 8235924
[TBL] [Abstract][Full Text] [Related]
19. Time required for elimination of Neisseria gonorrhoeae from the urogenital tract in men with symptomatic urethritis: comparison of oral and intramuscular single-dose therapy.
Haizlip J; Isbey SF; Hamilton HA; Jerse AE; Leone PA; Davis RH; Cohen MS
Sex Transm Dis; 1995; 22(3):145-8. PubMed ID: 7652655
[TBL] [Abstract][Full Text] [Related]
20. Single-dose efficacy of ofloxacin in uncomplicated gonorrhea.
Lutz FB
Am J Med; 1989 Dec; 87(6C):69S-74S. PubMed ID: 2513717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
